** Shares of Sigma Healthcare SIG.AX fall as much as 7% to A$2.930, their lowest levels since April 9
** Stock logs its biggest intraday pct gain since mid-December 2024
** SIG among top worst performers in the benchmark index
** UBS retains "neutral" rating, needs more conviction in the retail pharmacy franchiser's international growth outlook
** Co says 9-month normalised EBIT (unaudited) growth for combined group, compared with pcp for Chemist Warehouse Group (CWG) broadly consistent with the 36% growth achieved by CWG for 1H FY25
** Sigma Healthcare completed merger with CWG on February 12
** Average rating of eight analysts is "hold", their median PT is A$2.80 – according to data compiled by LSEG
(Reporting by Sneha Kumar in Bengaluru)
((Sneha.kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.